Scientific Board

Our customers operate in the front lines of the biomedical sciences. To offer them the best possible service and to be able to respond to the latest developments it is important to have a sounding board within the different disciplines of Biomedical Sciences. Our Scientific Advisory Board, consisting of leading scientists, signals the developments and gives us solicited and unsolicited advice. This way we remain up-to-date and state-of-the-art in helping you with our services and innovative solutions to bring your research further.

Our Scientific Advisory Board consists of:

Prof. Dr. Alain de Bruin

Oncology, Veterinary Pathology / Affiliation: University of Utrecht

Alain de Bruin’s group is interested in the molecular mechanisms that control cell proliferation in normal cells and in cancer cells. The group wants to understand how E2F transcription factors mediate the appropriate control of the cell cycle entry and exit that is required for normal development and tumour suppression. Read more>>

Prof. Dr. Esther Wolfs

Imaging, Cancer, and Charcot-Marie-Tooth Disease / Affiliation: BIOMED research institute, Hasselt University

The research group of Esther Wolfs uses microscopic and non-invasive small-animal imaging (BLI, PET, MRI) in cancer and peripheral neuropathies such as Charcot-Marie-Tooth disease type 1A (CMT1A). Her research involves the use of pluripotent stem cells (iPSC and embryonic stem cells) and adult stem cells (dental pulp stem cells, mesenchymal stem cells) for disease modelling and for therapeutic applications.

The lab houses several in vitro assays (co-cultures, 3D cultures and myelination assays) and in vivo disease models (cancer models and CMT1A).

Marije Slingerland, MD PhD

Medical Oncology / Affiliation: Leiden University Medical Center

As clinician Marije Slingerland participates in, among other things, the multidisciplinary LUMC upper GI cancer team, the head and neck cancer team and the melanoma team. She is principal (and co-) investigator of international and national clinical trials in gastrointestinal cancer and in head and neck cancer. She has initiated and is the principal investigator of a study exploring immune factors related to the efficacy of immunotherapy in treated patients by performing an in-depth analysis of systemic and intratumoral immune parameters.

Dr. Luuk Hawinkels

Cell-cell Interactions, Gastrointestinal Diseases / Affiliation: Leiden University Medical Center

The research laboratory Gastroenterology-Hepatology in the LUMC led by Dr. Hawinkels focusses on how interactions between different cell types (epithelial (tumour) cells, fibroblasts and immune cells) contribute to the pathogenesis and progression of gastrointestinal diseases. Our main focus in on inflammatory bowel disease (Ulcerative colitis and Crohn’s disease) and gastrointestinal cancers (oesophageal-, colorectal-, pancreatic cancer, hepatocellular carcinomas). Read more>> and Read more>>

Do you want to streamline your research?

Questions about how our services can accelerate your research? Reach out to one of our experts today and we can provide you with tailored advice on getting started